Literature DB >> 7473085

1995 William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections.

D G Armstrong1, P J Liswood, W F Todd.   

Abstract

This retrospective study reviewed the culture results of 112 admissions to a multidisciplinary diabetic foot care team with a primary diagnosis of infected diabetic pedal ulceration. An average of 1.5 +/- 0.9 species per patient (P < 0.0001) were isolated. Eighty-nine percent of wounds cultured grew two or fewer organisms. Anaerobic species were isolated in only 5% of all cultures. Of these isolates, the distinction between anaerobic colonization and true anaerobic infection is made. Results suggest that aggressive early hospitalization, coupled with aggressive intraoperative debridement, may yield less microbiologically complex infections that may be controlled with less expensive narrow spectrum antibiotic therapy. Diagnosis of the infected pedal ulceration of a patient with diabetes is a clinical one. If this diagnosis is combined with appropriate surgical intervention, microbiologic correlation, and antimicrobial therapy, the result may be a less complex hospital course and improved outcome.

Entities:  

Mesh:

Year:  1995        PMID: 7473085     DOI: 10.7547/87507315-85-10-533

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  14 in total

Review 1.  Wound microbiology and associated approaches to wound management.

Authors:  P G Bowler; B I Duerden; D G Armstrong
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  No need for biopsies: comparison of three sample techniques for wound microbiota determination.

Authors:  Kristine Gjødsbøl; Mette E Skindersoe; Jens Jørgen Christensen; Tonny Karlsmark; Bo Jørgensen; Anders Mørup Jensen; Bjarke M Klein; Michael K Sonnested; Karen A Krogfelt
Journal:  Int Wound J       Date:  2011-11-09       Impact factor: 3.315

Review 3.  Diabetic foot infections: stepwise medical and surgical management.

Authors:  David G Armstrong; Benjamin A Lipsky
Journal:  Int Wound J       Date:  2004-06       Impact factor: 3.315

Review 4.  Diabetic Foot Infections: an Update in Diagnosis and Management.

Authors:  Pinelopi Grigoropoulou; Ioanna Eleftheriadou; Edward B Jude; Nikolaos Tentolouris
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

5.  Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.

Authors:  Jeroen P Jansen; Ritesh Kumar; Yehuda Carmeli
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  From ulcer to infection: an update on clinical practice and adjunctive treatments of diabetic foot ulcers.

Authors:  C Abad; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

Review 7.  Wound bioburden and infection-related complications in diabetic foot ulcers.

Authors:  Sue E Gardner; Rita A Frantz
Journal:  Biol Res Nurs       Date:  2008-07       Impact factor: 2.522

8.  Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.

Authors:  Diane M Citron; Ellie J C Goldstein; C Vreni Merriam; Benjamin A Lipsky; Murray A Abramson
Journal:  J Clin Microbiol       Date:  2007-07-03       Impact factor: 5.948

Review 9.  Chronic Wound Healing: A Review of Current Management and Treatments.

Authors:  George Han; Roger Ceilley
Journal:  Adv Ther       Date:  2017-01-21       Impact factor: 3.845

10.  Plasma adiponectin, IL-6, hsCRP, and TNF-α levels in subject with diabetic foot and their correlation with clinical variables in a North Indian tertiary care hospital.

Authors:  Mohammad Zubair; Abida Malik; Jamal Ahmad
Journal:  Indian J Endocrinol Metab       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.